OVERVIEW

Phyllodes Tumors of the Breast: Overview, Updates, and Open Trials is organized by Duke University School of Medicine and will be held on Mar 17, 2021.

Accreditation:
In support of improving patient care, the Duke University Health System Department of Clinical Education and Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team.

Credit Designation:
Category 1: Duke University Health System Department of Clinical Education and Professional Development designates this Online Live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Description:
This webinar will review fibroepithelial tumors such as fibroadenoma and phyllodes, discuss the pre-surgical considerations and diagnostic workup, contemporary management of margins for phyllodes tumors by grade, discuss adjuvant treatment recommendations, and discuss open clinical trials.

Fibroepithelial breast lesions are commonly managed in the community, fibroadenomas are the most common breast masses in young women, and are diagnostically challenging to distinguish from phyllodes (and other rare stromal tumors), prior to complete surgical excision. NCCN guidelines have changed in the last 6 months and Duke is a site of clinical excellence in this rare tumor, with clinical trials offered.

Learning Objectives:
• When to have clinical suspicion of a phyllodes tumor in the pre-surgical setting
• How to select the appropriate operation for initial excision
• What is an appropriate margin width for a phyllodes tumor, by grade